The 2015 Cardiometabolic Health Congress (CMHC) will take place October 21-24, 2015 in Boston, MA. The CMHC 2015 curriculum will provide the most effective, current strategies for the prevention, diagnosis, and management of type 2 diabetes, atherosclerosis, hypertension, dyslipidemia, obesity, thrombosis, chronic kidney disease, insulin resistance, hypertriglyceridemia and related comorbidities.
The CMHC provides unprecedented access to the largest U.S.-based multidisciplinary cardiometabolic risk summit of 1,500+ clinicians world-renowned faculty, plenary sessions, and interactive case-based symposia to deliver on all counts - translating the most current clinical data into real-world solutions that will undoubtedly make a significant impact on your daily practice.
The CMHC welcomes industry involvement at its annual congress and recognizes the opportunity offered by this large gathering of 1500+ US-based endocrinologists, cardiologists, and PCPs. Seventy percent are physicians and 30% are high level, prescribing allied health (NPs and PAs), and all are in active practice. Importantly, 96% of these attendees say that they change how they practice based on what they hear and learn at the CMHC.
You are invited to take advantage of this unique opportunity to discuss the appropriate uses of your products in cardiometabolic disease with this ideal audience.
There are many ways for companies to leverage the CMHC promotionally, including our new Product Theater offering, our popular exhibit hall, and many exclusive sponsorship opportunities.